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http://wAbstract—Angiogenesis is a critical feature of plaque development in atherosclerosis and might play a key role in
both the initiation and later rupture of plaques. The precursory molecular or cellular pro-angiogenic events that
initiate plaque growth and that ultimately contribute to plaque instability, however, cannot be detected directly
with any current diagnostic modality. This study was designed to investigate the feasibility of ultrasoundmolecular
imaging of endothelial avb3 expression in vitro and in vivo using avb3-targeted ultrasound contrast agents (UCAs).
In the in vitro study, avb3 expression was confirmed by immunofluorescence in a murine endothelial cell line and
detected using the targeted UCA and ultrasound imaging at 18-MHz transmit frequency. In the in vivo study,
expression of endothelial avb3 integrin in murine carotid artery vessels and microvessels of the salivary gland
was quantified using targeted UCA and high-frequency ultrasound in seven animals. Our results indicated that
endothelial avb3 expression was significantly higher in the carotid arterial wall containing atherosclerotic lesions
than in arterial segments without any lesions. We also found that the salivary gland can be used as an internal pos-
itive control for successful binding of targeted UCA to avb3 integrin. In conclusion, avb3-targeted UCA allows non-
invasive assessment of the expression levels of avb3 on the vascular endothelium andmay provide potential insights
into early atherosclerotic plaque detection and treatment monitoring. (E-mail: v.daeichin@erasmusmc.nl or
http://www.erasmusmc.nl/thoraxcenterbme/)  2016 World Federation for Ultrasound in Medicine & Biology.
Key Words:Molecular imaging, Targeted microbubble, avb3 integrin, High-frequency ultrasound, Murine athero-
sclerosis, Endothelial cell, In vitro, In vivo.INTRODUCTION
Ultrasound molecular imaging features high sensitivity,
availability, rapid execution of imaging protocols and rela-
tively low cost (Kaufmann and Lindner 2007; van Rooij
et al. 2015), and its potential for imaging biological
processes at the molecular level has been illustrated. The
key element of this technique compared with regular
diagnostic ultrasound imaging is the use of ultrasound
contrast agents (UCAs) decorated with binding ligandsddress correspondence to: Verya Daeichin, Thoraxcenter Biomed-
gineering, Room Ee23.02, Erasmus MC, PO Box 2040, 3000
tterdam, The Netherlands. E-mail: v.daeichin@erasmusmc.nl or
ww.erasmusmc.nl/thoraxcenterbme/
2283such as antibodies and small peptides. These
functionalized UCAs, so-called targeted UCAs (tUCAs)
or targeted microbubbles, can bind to biomarkers involved
in various disease processes. As UCAs are blood pool
agents (Greis 2009), tUCAs can only bind to intravascular
biomarkers on intravenous administration. Combined with
dedicated ultrasound imaging sequences and the latest
transducer technology, ultrasound molecular imaging al-
lows quantitative assessment of molecular target expres-
sion with high sensitivity. The aforementioned features
of this technique have opened new diagnostic applications,
including the detection of atherosclerosis (Kaufmann
2009; Khanicheh et al. 2013a, 2013b; Liu et al. 2013;
Shim et al. 2015), thrombosis (Alonso et al. 2007),
2284 Ultrasound in Medicine and Biology Volume 42, Number 9, 2016neovasculature (Deshpande et al. 2011; Leong-Poi et al.
2003; Shelton et al. 2016; Stieger et al. 2008; Streeter
et al. 2013), lymph nodes (Hauff et al. 2004) and inflam-
mation (Bettinger et al. 2012; Davidson et al. 2014;
Lindner 2010; tenKate et al. 2010). It also provides helpful
insights into the genesis, progress and prevention of dis-
eases (Dayton and Ferrara 2002; Khanicheh et al. 2013a;
Klibanov 2006; Lanza et al. 1996; Lindner 2004; Liu
et al. 2013; Palmowski et al. 2008; Shim et al. 2015;
Streeter et al. 2013; van Rooij et al. 2015).
Atherosclerosis is characterized by accumulation of
lipids, inflammatory cells and connective tissue within the
arterial wall. A number of pathophysiologic mechanisms
are thought to be involved in the progression of an athero-
sclerotic lesion into a vulnerable plaque (Naghavi et al.
2003). Intraplaque neovascularization and adventitial vasa
vasorum have gained interest as a preceding or associated
factor in the development, progression and instability of
atherosclerotic plaques (Barger et al. 1984; Hellings et al.
2010; Langheinrich et al. 2007; Michel et al. 2011;
Moreno et al. 2006; Sluimer et al. 2008). The presence of
intraplaque neovascularization has been identified as an
independent predictor of intraplaque hemorrhage and
plaque rupture (Moreno et al. 2004; Purushothaman et al.
2003). Intraplaque neovascularization is therefore
increasingly investigated as a marker for the non-invasive
identification of vulnerable plaques. It has been reported
that angiogenic activity in the atherosclerotic plaques coin-
cideswithavb3-integrin by the adventitial vasa vasorumand
intraplaque neovascularization (Brooks et al. 1994;Haubner
2006; Hoshiga et al. 1995; Hynes 1987). Therefore, avb3
integrin is an appropriate biomarker for targeted
ultrasound imaging of intraplaque neovascularization and
adventitial vasa vasorum, whereas adhesion of tUCAs to
endothelial cells provides the signal enhancement. This
molecular marker has been used for ultrasound molecular
imaging of angiogenesis in tumors and hindlimb ischemia
(Ellegala 2003; Leong-Poi et al. 2003). Although avb3
integrin expression in atherosclerotic plaques has been
quantified ex vivo using near-infrared optical imaging in
mice (Tedesco et al. 2009) and in vivo with magnetic reso-
nance imaging in rabbits (Winter et al. 2003) and positron
emission tomography in mice (Laitinen et al. 2009), to the
best of our knowledge, no in vivo ultrasound molecular im-
aging of adventitial vasa vasorum and/or intraplaque neo-
vascularization with avb3 integrin has been reported.
Here, we provide in vitro and in vivo proof-of-
concept for molecular imaging of avb3 in carotid artery
lesions in apolipoprotein E-deficient (ApoE2/2) mice
with proven expansion of adventitial vasa vasorum
(Rademakers et al. 2013). We hypothesized that molecu-
lar imaging of avb3-integrin with tUCA could be used to
quantify the adventitial vasa vasorum underlying athero-
sclerosis plaques. To test our hypothesis, attachment ofavb3-targeted MicroMarker UCA to endothelial SVEC
cells was evaluated in vitro. Attachment of tUCA
in vivo and signal enhancement of the carotid plaques
were assessed in the ApoE2/2 mouse model.METHODS
A high-frequency pre-clinical ultrasound scanner,
with a 256-element linear array transducer (Vevo 2100
with MS250 probe, VisualSonics, Toronto, ON, Canada)
was used at 18 MHz. The transducer was operated at
10% transmit power, and a wide beam-width setting was
chosen to have a low, more uniform transmit pressure
over depth (Needles et al. 2010) (400 kPa, mechanical
index5 0.1). Side-by-sideB-mode andnon-linear contrast
mode (amplitudemodulation [Needles et al. 2010]) images
were acquired at a frame rate of 20 frames/s and a dynamic
range of 35. UCAwas prepared from Target-Ready Vevo
MicroMarker UCA (VisualSonics) according the manu-
facturer’s instructions. The UCA was targeted with bio-
tinylated antibodies against avb3 integrin (Catalog No.
551380, Clone RMV-7, BD Biosciences, San Jose, CA,
USA), an antibody previously successfully used to prepare
avb3-tUCA for ultrasound molecular imaging of tumor
angiogenesis (Leong-Poi et al. 2003). An inactive form
of biotinylated IgG(k) (Catalog No. 553923, BD Biosci-
ences) was used for making control UCA (cUCA).In vitro
Murine SV40 virus-modified endothelial cells
(SVEC) were purchased fromATCC (LGC Standards, We-
sel, Germany) and cultured in Dulbecco’sModified Eagle’s
Medium/Ham’s F-12 (Gibco, Life Technologies Europe,
Bleiswijk, Netherlands) with penicillin–streptomycin solu-
tion (1% v/v solution containing 5,000 units penicillin
[Gibco] and 5 mg streptomycin [Gibco] per milliliter)
and 10% heat-inactivated fetal calf serum (Gibco) in a hu-
midified atmosphere of 5% CO2 at 37
C. Cells were
cultured up to passage 5 in acoustically transparent Opti-
Cell (NUNC, Wiesbaden, Germany) chambers on only
one of the two membranes until 100% confluence. avb3
expression was determined by fluorescence immunostain-
ing. The cells were fixed in 4% formaldehyde for 5 min
and blocked in 5% goat serum in phosphate-buffered saline
(PBS) solution for 1 h. After fixation, 1 3 1-cm pieces of
the OptiCell membrane containing cells were cut out.
These specimens were incubated with rat anti-mouse anti-
body against avb3 integrin (1:100; BD Biosciences) for
1.5 h. After thorough washing with PBS, the specimens
were incubated with goat anti-rat antibody conjugated
with AlexaFluor 488 (1:1,000; Invitrogen, Groningen,
Netherlands) for 1 h. As a control, fixed cells were blocked
and incubatedwith rat anti-mouse antibody againstavb3 in-
tegrin only or goat anti-rat antibody conjugated with
Imaging endothelial avb3 expression with targeted UCA dV. DAEICHIN et al. 2285AlexaFluor488 only. All procedures were carried out at
room temperature. After incubation, the specimens were
washed with PBS and embedded in Mowiol (Sigma-Al-
drich, Zwijndrecht, Netherlands) with Hoechst 33342 (In-
vitrogen; 5 mg/mL) to stain the cell nuclei. Fluorescence
microscopy was performed with a fluorescence Olympus
microscope equipped with an AxioCam MRc camera
(Carl Zeiss, Sliedrecht, Netherlands) and 403 water-
immersed objective (LUMPlanFI, NA 0.8, Olympus).
To assess the adhesion of tUCAs to SVEC cells, the
cells were cultured as previously described, and 30 mL of
avb3-tUCA or cUCAwas added to the cells. The OptiCell
was then turned cell side up, to let UCA adhere to the cells
by flotation, and incubated at 37C for 5 min. After incu-
bation, the OptiCell was inverted (cell side down) and
incubated for another 5 min at 37C to allow UCA that
did not adhere to the cells to float to the top membrane
of the OptiCell chamber. For each specimen, 20 random
fields of view were acquired for both UCA adhering to
cells on the bottom and free-floating UCA on top of the
OptiCell. The ratio of adhered UCA to total adhered
plus free-floating UCA was calculated and presented as
the percentage of attached UCA.
To determinewhether tUCA adherent to avb3-integrin
can be detected by high-frequency non-linear contrast im-
aging, cells were incubated with tUCA as described above,
and then the membrane of the OptiCell that did not contain
the cells was cut out. Cells were washed with 37C fresh
warm medium and placed in the tank filled with PBS, the
temperature of which was maintained at 37C. The 18-
MHz probe was then positioned above the OptiCell. To
prevent the overwhelming specular reflection from the
OptiCell interface and to obscure the scattering signal
from the sample under examination received by the US
transducer, the OptiCell was placed tilted at a 20 angle
with respect to the direction of the ultrasound beam; thus,
specular reflected US signals from the OptiCell could not
reach the US transducer (Klibanov 2006). First, a 2-D im-
age was acquired, and the tUCA in this 2-D imaging plane
were destroyed using a flash burst. In addition to the 2-D
images, 3-D B-mode and non-linear contrast mode images
were acquired by mounting the probe on a linear stepper
motor (VisualSonics). The probe was translated over
4.9 mm, while acquiring frames every 0.032 mm (beam
overlap percentage 50%, pixel size of 0.0262 mm in
contrast mode). The series of images was then rendered
in 3-D using the Vevo 2100 3-D Mode software
(VisualSonics).
In vivo
Animal experiments were approved by the regulato-
ry authority of Maastricht University and performed in
compliance with Dutch government regulation guide-
lines. Hypercholesterolemic male ApoE knockout mice(n 5 7) on a C57/BI6 background from an in-house
breeding colony (originally from Iffa Credo, Lyon,
France) were fed normal chow until the age of 50 wk.
Mice were anesthetized with ketamine (0.1 g/kg) and xy-
lazine (0.02 g/kg) by subcutaneous injection and pre-
operative ibuprofen (subcutaneously). The animals were
intubated and artificially ventilated using room air at
the rate of 160 strokes/min and stroke volume of
250 mL (Mouse Microvent, Hugo Sachs, Germany).
The left jugular vein was exposed, and a heat-stretched
polyethylene-25 cannula was inserted (1.5 cm) and sub-
cutaneously guided to the neck of the mouse. Here the
catheter was fixed with sutures, extended, filled with hep-
arinized saline (10 U/mL) and plugged. Animals were
placed on the VevoRail System heating stage (VisualSon-
ics), and ultrasound imaging was performed. For each an-
imal, cUCA and tUCA (100 mL each) were injected with
20-min intervals between injections using a programma-
ble syringe pump (11 Pico Plus Elite, Harvard Apparatus,
Kent, UK) at the rate of 600 mL/min. The focus of the
transducer was set at 7 mm, at the upper wall of the right
common carotid artery. A field of view of the right com-
mon carotid artery and its bifurcation was chosen. The
right salivary gland located above the right carotid was
also in the imaging field. B-Mode gain was 20 dB, and
contrast gain was 30 dB. DICOM (Digital Imaging and
Communications in Medicine) images were exported to
MATLAB (Version R2012 b, The MathWorks, Natick,
MA, USA) for further off-line processing.
After injection of the UCA, about 10 min is required
for UCA clearance from the blood (van Rooij et al. 2015).
This waiting period also leaves more time for the tUCA to
adhere to the avb3 binding sites. Next, a series of about
300 frames (10 s) was acquired with high-intensity ul-
trasound bursts (flash with standard internal destruction
burst of 10-cycle square envelope at 18 MHz and 100%
power for a total duration of exposure of 1 s) in the middle
to disrupt the UCA in the imaging plane.
Subsets of the images (100 frames) captured 10 min
after injecting the UCA were used for quantification of
the bound UCA in the region of interest (ROI) around
the carotid plaques, the healthy part of the carotid artery
and in the salivary gland. The captured frames with a flash
in the middle to destroy the UCA in the imaging plane
were separated into two groups: pre-flash and post-flash
groups (50 frames each from pre- and post-flash groups).
The noise levels in each data set were obtained by drawing
a ROI in the background of a contrast frame immediately
after the flash pulse and calculating the mean intensity
value (m) and standard deviation (s) in the ROI. Then,
all image intensities below a noise threshold level of
(m 1 4) 3 s were set to zero (Daeichin et al. 2015a).
Next, averaging was applied on all the frames of each
pre- and post-flash group, resulting in a single mean image
2286 Ultrasound in Medicine and Biology Volume 42, Number 9, 2016for each of these groups. The averaging emphasizes the
signal of stationary contrast spots. Each of the single
pre- and post-flash mean images was then smoothed using
a 2-D Gaussian filter of 33 3 pixels with sigma5 1 to re-
move speckles smaller than the characteristic bubble size
(0.07863 0.0786 mm). The resulting post-flash mean im-
ages were subtracted from the pre-flash counterpart to
cancel signals of non-stationary contrast spots, stationary
artifacts and remaining tissue signal. In the subtracted
mean images, mean intensity within each ROI was calcu-
lated and presented as molecular signals. Respiratory mo-
tion artifacts were absent and therefore not relevant.Tissue handling
At sacrifice, blood was drawn from the right ven-
tricular apex. Subsequently the mice were perfusion
fixed via the left cardiac ventricles with 20 mL sodium
nitroprusside (0.1 mg/mL in PBS, Sigma-Aldrich,
Seelze, Germany), followed by 1% paraformaldehyde
(PFA). The right carotid arteries and salivary glands
were excised, fixed in 1% PFA for 24 h and embedded
in paraffin. The right carotid arteries and salivary glands
were serially sectioned (4 mm) and stained at 20-mm in-
tervals with hematoxylin and eosin (HE, Sigma-Aldrich)
for microscopic examination. Serial sections were sub-
jected to heat-induced epitope retrieval (DAKO target
retrieval) and stained with rat anti-mouse MAC3
(1:400, clone M3/84, Becton & Dickinson) for 1 h at
room temperature to visualize plaque macrophages.
Slides were subsequently incubated with biotin-
conjugated rabbit anti-rat secondary antibody (Jackson
Immunoresearch), followed by horseradish peroxidase
ABC (Vector, ABC systems), and staining was visual-
ized using 3,3-diaminobenzidine tetrahydrochloride
(brown precipitate, DAKO). Endothelial cells were
stained overnight at 4C with CD31 primary antibody
(1:50, BD Pharmingen) after trypsin treatment (0.1%
trypsin, 0.1% CaCl2, pH 7.8) for 20 min at 37
C
(Muchir et al. 2009) for epitope retrieval. Slides were
further incubated with mouse-absorbed rabbit anti-rat
(Vector), horseradish peroxidase-conjugated anti-rabbit
antibody (BrightVision, Immunologic) to amplify signal
and visualized using diaminobenzidine.Statistical evaluation
Statistical analysis for integrin expression and num-
ber of UCAmicrobubbles adherent to the SVEC cells was
performed using an unpaired t-test. In vivo, quantified
molecular signal based on video intensity of contrast-
enhanced sonograms of processed images in seven ani-
mals was analyzed using a paired t-test and expressed
as medians and interquartile ranges (p, 0.01 was consid-
ered to indicate significance).RESULTS
In vitro
Immunofluorescence staining of avb3-integrin
expression on SVEC cell membranes (Fig. 1f) revealed
that the ligand is expressed on the cell surface, espe-
cially in cell–cell border regions. No fluorescence was
observed when only the avb3-antibody or only the
goat anti-rat antibody conjugated with AlexaFluor488
was used. These stainings also prove that the avb3-
tUCA used in this study can adhere to murine endothe-
lial cells. To examine the binding affinity of UCA, avb3-
tUCA or cUCAwas incubated with live SVEC cells. We
observed that significantly more (3.7 times more,
p , 0.0001) tUCA (Fig. 1b) than cUCA attached to
the cells (Fig. 1a).
Figure 2a is a schematic of the imaging setup.
Figure 2b illustrates the ultrasonic signals of SVEC cells
to which tUCA was bound. The contrast-to-tissue ratio
was 30 dB. In Figure 2b, the gray-scale B-mode image
overlies the contrast-mode image. The band in the middle
of Figure 2b showing no green signal indicates the
destruction of the tUCAwith the flash burst.In vivo
To examine further the application of avb3-tUCA for
imaging avb3-integrin expression in vivo, the following
locations were examined in ApoE2/2 mice: atheroscle-
rotic lesions at the bifurcation of the carotid artery, part
of the wall of the common carotid artery containing no
atherosclerotic lesions and the salivary gland. Figure 3a
is a micrograph of an ApoE2/2 mouse indicating the
anatomic structure and presence of atherosclerotic le-
sions in the aortic arch (AA), brachiocephalic trunk
(BT) and right carotid bifurcation (RCB). In Figure 3b
and c are examples of cross-sectional histopathologic
sections revealing the morphology of the carotid artery
and the atherosclerosis lesions are presented. Large and
advanced atherosclerosis lesions at and around the carotid
bifurcation are visible in Figure 3b, and the absence of
atherosclerotic lesions in the right common carotid
(RCC) artery can be observed in Figure 3c.
Representative B-mode and contrast mode images of
the right carotid and salivary gland; analyzed ROIs for the
plaque area and salivary gland; and a no-plaque ROI in the
common carotid are provided in Figure 4. Similar to
in vitro results, therewas evident enhancement of the ultra-
sound signal from the avb3-tUCA adhering to the vessel
walls in the carotid bifurcation (Fig. 4c) and salivary gland
(Fig. 4e) after applying our quantification method. Only a
weak molecular signal was detected in the case of cUCA
injections (Fig. 4d, f). Enhancement of the ultrasound
signal in the no-plaque ROI (Fig. 4g, h) was significantly
(p , 0.01) lower than that in the plaque ROI.
Fig. 1. avb3-Integrin expression in cultured SVEC cells. (a, b) Bright-field images of control ultrasound contrast agent
(cUCA) (a) and targeted ultrasound contrast agent (tUCA) (b). Arrows point to cUCA, and arrowheads point to tUCA. (c)
The percentages of tUCA and cUCAmicrobubbles that adhered to SVEC cells are illustrated as interquartile ranges. (d, e)
Corresponding bright-field image (d) and staining of cell nuclei (e). Immunofluorescence staining of avb3-integrin ex-
pressed on cell membrane of SVECs (f). Bar 5 50 mm.
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que ROI revealed that the difference between the mo-
lecular signals using avb3-tUCA (4.25 6 0.84 arbitrary
units [a.u.]) and those using cUCA (1.08 6 0.39 a.u.)
was statistically significant (Fig. 5). There was also a
difference in signal intensity for the salivary gland
(6.61 6 1.23 a.u. for tUCA vs. 2.63 6 0.60 a.u. for
cUCA) (Fig. 5). However there was no statistically sig-
nificant difference for avb3-tUCA and cUCA in the no-
plaque ROI (1.16 6 0.24 a.u. for tUCA and
0.41 6 0.07 a.u. cUCA) (Fig. 5). Also, the molecular
signal in the plaque ROI (4.25 6 0.84 a.u.) was signif-
icantly higher than that for the no-plaque ROI
(1.16 6 0.24 a.u.) for the tUCA. As expected, thisFig. 2. Ultrasound molecular imaging of avb3-tUCA expressio
imaging of avb3-tUCA expression in vitro. (b) B-Mode (gray)
image in three dimensions to detect avb3 expression via avb3-tU
aging was performed with the Vevo 2100 ultrasounddifference was not significant for the cUCA
(1.08 6 0.39 a.u. vs. 0.41 6 0.07 a.u.).
To validate the results of ultrasonography, the ca-
rotid artery and salivary gland of mice were harvested
and subsequently analyzed for the presence of blood ves-
sels and macrophages by CD31 and MAC3 staining,
respectively. Results indicated expanded adventitial
vasa vasorum and numerous macrophages in the carotid
artery plaques (Fig. 6a, c) and microvessels and macro-
phages in the salivary gland (Fig. 6b, d).
Also to validate the results of ultrasonography, the
carotid artery and salivary gland of mice were harvested
and subsequently analyzed for the presence of avb3
expression, blood vessels and macrophages by avb3,n in vitro. (a) Schematic of in vitro ultrasound molecular
image with overlying non-linear contrast mode (green)
CA adherent to SVEC cells cultured in an OptiCell. Im-
imaging system and MS250 probe at 18 MHz.
Fig. 3. Micrograph and cross-sectional histopathologic sections of a 50-wk-old ApoE2/2 mouse. (a) Anatomic structure
of heart, left carotid (LC) and right carotid; atherosclerosis lesions in the aortic arch (AA), brachiocephalic trunk (BT) and
right carotid bifurcation (RCB); and absence of lesions in the right common carotid (RCC). (b) Corresponding hematox-
ylin and eosin-stained slices just before, at and just after the carotid bifurcation where the advanced atherosclerosis lesions
are visible. (c) Corresponding hematoxylin and eosin-stained slice from the middle of the right common carotid (RCC)
where there is no atherosclerotic lesion.
2288 Ultrasound in Medicine and Biology Volume 42, Number 9, 2016CD31 andMAC3 staining, respectively. Results indicated
the presence of avb3, expanded adventitial vasa vasorum,
and numerous macrophages in the carotid artery plaques
(Fig. 6a, c) and microvessels and macrophages in the sali-
vary gland (Fig. 6b, d).DISCUSSION
Our in vitro and in vivo results revealed successful
binding of tUCA to avb3-integrin, as well as successful
detection of avb3-tUCA corresponding to the intensity
of avb3-integrin expression on endothelial cells. Expres-
sion of avb3 was confirmed by immunocytochemistry
in vitro. In vivo, immunohistochemical avb3 signals in
plaques and the salivary gland are most likely derived
from endothelial cells and macrophages, known to ex-
press avb3-integrin (Antonov et al. 2004; Brooks et al.
1994; Hoshiga et al. 1995).
It is known that macrophages play an important role
in the pathogenesis of atherosclerosis and strongly corre-
late with plaque vulnerability (Boyle 2005; Redgrave
et al. 2006). The expression of avb3-integrin on
activated macrophages, which are recruited to the
arterial wall, had been confirmed earlier (Antonov
et al. 2004). However, our results are especially valuable
because they can provide a strategy for direct and selec-
tive intraplaque neovascularization evaluation in terms
of spatial extent and amount of endothelial avb3-integrinin a non-invasive or minimally invasive manner. Such
separation between avb3-integrin expressed on macro-
phages and endothelial cells is possible with ultrasound
molecular imaging because UCAs remain exclusively
intravascular on intravenous administration, thereby
minimizing non-specific signals from extravasated
contrast material. This separation was not possible for
the avb3 expression studies of atherosclerosis with
near-infrared optical imaging (Tedesco et al. 2009),
magnetic resonance imaging (Winter et al. 2003) and
positron emission tomography (Laitinen et al. 2009)
because the contrast agents used in these studies are
small and can therefore extravasate. Although it can be
argued that the micron-sized microbubbles in UCAs
can extravasate from the leaky adventitial vasa vasorum,
further investigation is required to confirm such a
hypothesis.
Numerous investigators have adopted approaches in
which ultrasound molecular images have been acquired
through the use of UCAs targeted to many biomarkers
related to atherosclerosis, such as CD81 (Yan et al.
2012), ICAM-1 (Demos et al. 1999), VCAM-1
(Hamilton et al. 2004; Khanicheh et al. 2013a, 2013b;
Liu et al. 2013), P-selectin (Lindner et al. 2001; Liu
et al. 2013), platelet glycoprotein Iba (Khanicheh et al.
2013b; Liu et al. 2013; Shim et al. 2015) and von
Willebrand factor (Shim et al. 2015). However, to the
best of our knowledge, this is the first study reporting
Fig. 4. Molecular sonogram of carotid artery vessels and salivary gland. (a) B-Mode image of the right carotid and right
salivary gland with a region of interest (ROI) in the salivary gland (yellow lines), around the plaque at the carotid bifur-
cation (yellow rectangle) and around the common carotid artery (yellow rectangle) where no plaque was present. The
yellow dashed rectangle indicates the size of the sonograms in (e) and (f). (b) Non-linear contrast mode image (maximum
intensity projection over 100 frames) of the right carotid and salivary gland after injection of the ultrasound contrast agent.
ROIs are represented by yellow lines (salivary gland) and rectangles (plaque ROI and no plaque ROI). (c) Detected bound
targeted UCA (tUCA) in the plaque ROI. (d) Detected bound control UCA (cUCA) plaque ROI. (e) Detected bound tUCA
in the salivary gland ROI. (f) Detected bound cUCA in the salivary gland ROI. (g) Detected tUCA in the ROI around the
common carotid artery wall, where no plaque is present. (h) Detected cUCA in the ROI around the common carotid artery
wall, where no plaque is present.
Imaging endothelial avb3 expression with targeted UCA dV. DAEICHIN et al. 2289successful in vivo ultrasound molecular imaging of
adventitial vasa vasorum in atherosclerotic plaques using
UCA targeted to avb3-integrin in a mouse model ofFig. 5. Quantification of molecular signals (medians and inter-
quartile ranges) in the plaque region of interest (ROI), salivary
gland and no-plaque ROI for control (cUCA) and targeted
(tUCA) ultrasound contrast agent. *p , 0.01.atherosclerosis. The advantage of using avb3-integrin as
a target for tUCA over other atherosclerotic biomarkers,
such as CD81, ICAM-1, VCAM-1, P-selectin, platelet
glycoprotein Iba and von Willebrand factor, is the ability
to identify intraplaque neovascularization, which has
been identified as an independent predictor of intraplaque
hemorrhage and plaque rupture. The avb3-tUCA could
therefore be used to assess the risk of rupture of athero-
sclerotic plaques. Use of avb3-tUCA to assess adventitial
vasa vasorum will have advantages over use of non-
targeted microbubbles that are currently already used in
the clinic for adventitial vasa vasorum assessment
(Staub et al. 2010; van den Oord et al. 2015). These
advantages include (i) a better assessment of adventitial
vasa vasorum and intraplaque neovascularization as the
plaque can be imaged in three dimensions by, for
example, mechanical stepping of the transducer; and
(ii) assessment of the far-wall plaque which is now very
limited for non-targeted microbubbles because of the
pseudo-enhancement artifact resulting from free-
floating microbubbles in the lumen (ten Kate et al. 2012).
Fig. 6. (a, b) Microvessels (CD31 staining) and (c, d) macrophages (MAC3 staining) in atherosclerosis plaque of the right
carotid artery (a, c) and right salivary gland (b, d). Insets show origin of magnification.
2290 Ultrasound in Medicine and Biology Volume 42, Number 9, 2016In our study, we chose the carotid artery vessels as the
target for examination for the following reasons: First, it is
believed that the carotid artery is themost reproducible site
for studies of lesions in mice (Ni et al. 2009; Rigatelli and
Zanchetta 2005). Second, the carotid artery vessels are
superficially located and hence readily accessible for
ultrasound imaging systems. Third, the salivary gland,
which is in the field of view on top of the carotid, is a
suitable internal positive control for binding of tUCA in
such a murine model. Finally, the common carotid distal
of the bifurcation is usually free from lesions and, hence,
an ideal intra-animal negative control because it is in the
same field of view.
We observed avb3-tUCA attached to the middle part
of the common carotid artery, a location where no athero-
sclerotic lesions were present. This may be explained by
avb3-integrin expression in normal arteries, as reported
previously (Hoshiga et al. 1995). However, the intensity
of avb3 expression in the healthy part of the common ca-
rotid artery was significantly lower than that in the plaque
ROI. As expected, there was no statistical significant dif-
ference between the molecular signal in the plaque ROI
and that in the no-plaque ROI for the cUCA, as well as
for tUCA versus cUCA in the part of the vessel without
plaques. Subsequent work to further improve the signal-
to-baseline would add to the power of this technique.
The salivary gland is a large and very well vascular-
ized organ, which is located above the right carotid in our
imaging field of view. Microvessel density in the gland is
high, hence so is the associated avb3-integrin expression.Therefore, it is an ideal target as an internal positive con-
trol for successful binding of avb3-tUCA to its targets.
Our immunocytochemistry analysis of the salivary glands
also confirmed the presence of macrophages and micro-
vessels in this gland.
Our quantification method ensures that only the
signal from bound UCA is enhanced and considered as
molecular signal. Shortly after injection of the UCA,
the intensity of contrast in the ROI increased rapidly
and reached a maximum, and this was followed by a
slow decay in intensity for both tUCA and cUCA. How-
ever, 10 min after the injection, because of the binding of
the tUCA to the avb3-integrin, the level of intensity is ex-
pected to be higher for tUCA than for cUCA. Ideally,
10 min after injection of cUCA, image intensity in the
ROI should fall back to the baseline level (similar to the
level before UCA injection), and there should be no dif-
ference in image intensity before and after the flash pulse.
On the other hand, there will be a difference in the inten-
sity levels for tUCA before and after the flash because of
the destruction of bound tUCA, which is a measure of the
molecular signals in the ROI. Even 10 min after injection,
there will be recirculating unbound UCA for both tUCA
and cUCA injections. Therefore, the actual difference in
the intensity of the pre- and post-flash frames depends on
the amount of both bound and unbound UCA in the ROI.
The increase in intensity after the flash is also an indica-
tion of the presence of recirculating UCA. The processing
steps, such as averaging pre- and post-flash frames and
subtracting the result frames from each other, ensures
Imaging endothelial avb3 expression with targeted UCA dV. DAEICHIN et al. 2291that tissue artifacts are minimized and only the stationary
contrast spots are enhanced. We had previously found, in
both in vitro and in vivo comparison studies, that the
amplitude-modulation pulse sequence used to extract
the non-linear response of the UCA at the fundamental
frequency is a suitable non-linear contrast mode for imag-
ing targets such as mouse carotid artery with the imaging
platform used in this study (Daeichin et al. 2015b).
There are several limitations to this study. First, in
the preparation of the targeted UCA, biotin–avidin
bridging was used to non-covalently and very stably
couple the avb3 antibody to the lipid microbubble
coating. However, this strategy may not be translated to
humans, as avidin is immunogenic in humans
(Petronzelli et al. 2010). On the other hand, this avidin–
biotin coupling can be avoided by covalently linking
the antibody to the lipid microbubble coating. A covalent
linkage of cyclic RGD, a human compatible ligand for
avb3, has already been reported for tUCA (Anderson
et al. 2011). In addition, these components are commer-
cially available. Second, it cannot be assumed that the
murine expression of avb3 is fully identical to clinical
disease-related avb3 expression. In the clinical setting,
more complex factors such as disease-related inducers,
individual differences and intricate signal pathways are
often involved in the regulation of avb3 expression.
Although there remains a long road to translation of
this technique from the animal model to the clinical situ-
ation, it would be desirable to relate the level of video-
intensity signal from the tUCA to the stage of the disease
and to predict the risk of future clinical cardiovascular
events. Also, precise spatial correlation between ultraso-
nography and immunohistology is not always possible
because of the difficulty involved in spatially matching
the ultrasound plane with histologic sections and the
fact that 2-D ultrasonography is formed from signals
received over a beam elevation of almost a millimeter.
Accuracy of avb3 quantification using the tUCA may
be limited by some degree of non-specific binding
because of the expression of avb3 by the vascular endo-
thelium. In addition, more complex factors, such as
acoustic radiation force, UCA concentration, blood flow
velocity and tUCA affinity, are involved and need to be
further investigated.CONCLUSIONS
This article describes the successful preparation of
avb3-targeted microbubbles and the potential of target-
specific UCA to quantitatively detect the expression of
avb3 integrin in vitro and in vivo. Our initial experience
in molecular ultrasonography using avb3-tUCA has indi-
cated that it may enable in vitro and in vivomolecular im-
aging of avb3 expression on actively sprouting vascularendothelium. This imaging modality may provide refer-
ence values for relative expression of avb3 and informa-
tion likely to be very useful to address the detection,
prognosis and vulnerable potential of atherosclerosis or
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